Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06286800 · ClinicalTrials.gov registry record · NA

Personalized Transcranial Direct Current Stimulation in Stroke Recovery

A NA study of Stroke and Ischemic Stroke, sponsored by The Methodist Hospital Research Institute.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06286800 is a NA study of Stroke and Ischemic Stroke that is actively recruiting participants, run by The Methodist Hospital Research Institute. The registered enrollment target is 80 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06286800, a NA study of Stroke and Ischemic Stroke, is actively recruiting participants, sponsored by The Methodist Hospital Research Institute.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The central objective of this application is to explore the neural substrate of personalized tDCS (ptDCS) and to determine whether the paradigm for each stroke patient can predict the amount of sustained clinical improvement through increased connectivity as measured by a biomarker of plasticity.

Interventions

  • DEVICE Transcranial direct current stimulation (tDCS) with OT
  • DEVICE Sham tDCS with OT

Study Locations (1)

Texas

  • Houston Methodist Hospital - Houston

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-12-18
Est. Completion 2027-09-14
Phase NA

What the Registry Record Tells You About NCT06286800

The ClinicalTrials.gov registry entry for NCT06286800 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Transcranial direct current stimulation (tDCS) with OT is the first listed.

NCT06286800 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06286800 about?

NCT06286800 is a clinical study titled "Personalized Transcranial Direct Current Stimulation in Stroke Recovery". The central objective of this application is to explore the neural substrate of personalized tDCS (ptDCS) and to determine whether the paradigm for each stroke patient can predict the amount of sustained clinical improvement through increased connectivity as measured by a biomarker of plasticity.

What is the current status of trial NCT06286800?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-12-18. Estimated completion is 2027-09-14.

What conditions does trial NCT06286800 study?

This clinical trial studies the following conditions: Stroke, Ischemic Stroke, Chronic Stroke, Hemorrhage Brain.

What interventions are being tested in trial NCT06286800?

The interventions under investigation include: Transcranial direct current stimulation (tDCS) with OT (DEVICE), Sham tDCS with OT (DEVICE).

Who is sponsoring clinical trial NCT06286800?

This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06286800 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.